By creating efficiencies with technology, CROs have an opportunity to build clinical trials of the future.
For many years, artificial intelligence (AI), machine learning (ML) and natural language processing (NLP) had a reputation in the biopharmaceutical industry as flashy buzzwords, with little concrete evidence to back up their promise. Over time, this lack of understanding has created drawn-out anticipation, leaving many skeptical about the true value of these tools.
As the
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Med Device AVS Raises Additional $8.8M for $28.8M Series B
What You Should Know:
- AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced today that it closed an additional $8.8 million in new financing, bringing its Series B round to $28.8 million total.
- The funding will continue to support clinical trials for the company’s device for pulsatile intravascular lithotripsy (PIVL) in peripheral cases, while advancing preclinical work for an expanded
Read More
AI-Enabled Butterfly Network Lung Tool Receives FDA Clearance
What You Should Know:
- Today, Butterfly Network announced it received 510(k) clearance from the FDA for a groundbreaking AI-enabled tool named AI-enabled Auto B-line Counter that will help physicians assess adults’ lungs and accelerate providers’ abilities to make informed treatment decisions. Butterfly used data inputs from hundreds of sites across the country to train and develop its AI algorithms, offering potential for a broad and diverse range of age, gender, body mass index, ethnicity,
Read More
Exec Hires: CitiusTech Appoints Rajan Kohli as CEO
What You Should Know:
CitiusTech Healthcare Technology Pvt. Ltd., announced that its Board of Directors has appointed Rajan Kohli, an experienced technology executive as Chief Executive Officer.Mr. Kohli joins CitiusTech from Wipro, a global leader in technology services and solutions, where he spent nearly three decades and was responsible for $6 billion in annual revenues.
Read More
Dionysus Accelerates Advancement in Maternal Health with Artificial Intelligence
What You Should Know:
Today, the National Institutes of Health (NIH) announced that Dionysus Digital Health, Inc. (Dionysus), a digital health company engaged in the development of precise medical insights using a proprietary digital and epigenetic analysis platform, was selected to move to the next phase of the Rapid Acceleration of Diagnostics Technology (RADx® Tech) for Maternal Health Challenge. The $8 million cash prize challenge will accelerate the development of technologies to
Read More
VIVE 2023: 6 Digital Health Executives Share Their Key Takeaways
A common thread throughout my conversations at ViVE was the increased competition for health consumers. Larger health systems are continuing to be fragmented by smaller specialties, like Northwell Health, which reported their outpatient care volumes are continuing to rise. Free-standing surgery centers, ER, urgent care, primary care, imaging centers and so on, are monitoring large healthcare systems looking for ways to extract the most profitable arms and business from them. As this continues to
Read More
Kahun Integrates AI Physician Chatbot with ChatGPT
What You Should Know:
- Kahun, an evidence-based clinical reasoning tool for physicians announced it is integrating its AI chatbot for physicians with ChatGPT, an open-source AI chatbot platform to build on the advanced Large Language Model’s (LLM) ability to engage in human-like conversation with patients.
- By integrating ChatGPT, Kahun builds on the language model’s text fluency to boost patient engagement pre-visit, cutting the time needed for the healthcare provider to conduct the
Read More
Phenomix Sciences Launches Saliva Test to Predict Obesity Phenotype
What You Should Know:
- Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces today the launch of its first therapy selection test, the My Phenome Hungry Gut test.
- This is a first-of-its-kind obesity test and will determine if a patient’s phenotype is Hungry Gut (Satiety) or feeling hungry shortly after eating a meal. If a patient is Hungry Gut phenotyped, providers are able to more precisely and
Read More
Hybrid Healthcare and The New Normal: Biggest Adjustments for Healthcare Organizations
The adoption of virtual health has increased dramatically since March 2020, with 150 million telehealth claims in less than two years. Like other revolutionary innovations throughout history, healthcare innovation is necessitated by time — and unmet needs. So many struggled to create virtual care solutions during the pandemic, and many technology companies jumped into the telehealth space because of the unmet needs of patients. But the pandemic era is soon coming to an end, leaving telehealth to
Read More
Inato Raises $20M to Make Clinical Trials More Inclusive
What You Should Know:
- Inato, a technology platform that connects pharma companies (trial sponsors) with community-based trial sites raises $20M in new funding (A2) led by Cathay Innovation with participation from existing investor Obvious Ventures and new investors La Maison and Top Harvest Capital. Inato works with many of the top 30 pharmaceutical companies worldwide to make clinical trials more inclusive.
- The new funding will fuel Inato’s continued product innovation, international
Read More
